J. W. Brooks

Operation BUSTER, Nevada Proving Grounds, October-November 1951, Project 4.2, Thermal Effects on Animals (Dogs),

J. W. Brooks, W. T. Ham, R. C. Williams, 1952 .

The effect of addiction to and abstinence from morphine on rat tissue catecholamine and serotonin levels

J. W. Brooks, J. Sloan, W. Martin, 1963, Psychopharmacologia.

Cannabinoids and analgesia

J. W. Brooks, 2002 .

Catecholamine and 17-hydroxycorticosteroid excretion during a cycle of morphine dependence in man.

J. W. Brooks, D. Jasinski, J. Sloan, 1969, Journal of psychiatric research.

Urinary excretion and plasma levels of 17-hydroxycorticosteroids during a cycle of addiction to morphine.

J. W. Brooks, H. F. Fraser, A. J. Eisenman, 1961, The Journal of pharmacology and experimental therapeutics.

Cannabinoids and pain

J. W. Brooks, W. Farquhar-Smith, Jason W. Brooks, 2003 .

Comparison of the effects of single Doses of morphine and thebaine on body temperature, activity, and brain and heart levels of catecholamines and serotonin

J. W. Brooks, J. Sloan, W. Martin, 1962, Psychopharmacologia.

Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB(1)/CB(2) receptors.

J. W. Brooks, C. Ledent, T. Bisogno, 2002, European journal of pharmacology.

(S)-AMPA inhibits electrically evoked calcitonin gene-related peptide (CGRP) release from the rat dorsal horn: reversal by cannabinoid receptor antagonist SR141716A

J. W. Brooks, M. Malcangio, A. Rice, 2004, Neuroscience Letters.